| Parameter | Score |
|---|---|
| 1. Scale | A |
| 2. Study Population | A |
| 3. Samples | A |
| 4. Measurand | A |
| 5. Pre-Analytical | A |
| 6. Replicate Analysis | A |
| 7. Steady State | A |
| 8. Outlier Analysis | A |
| 9. Normality | A |
| 10. Variance Homogeneity | C |
| 11. ANOVA | A |
| 12. CI | A |
| 13. No of Results | A |
| 14. Concentrations | A |
| 15. Total Score | C10 |
| Comment |
| Parameter | Score |
|---|---|
| Matrix | Serum |
| Measurand | Alkaline phosphatase (ALP) bone isoenzyme |
| Unit | IU / L |
| Overall Analytical Principle Method | Immunoassay; RIA |
| Number of Subjects | 11 |
| Number of Subjects included in BV estimation | 11 |
| Ethinicity | Unknown |
| Age Mean / Median | |
| Age Min | 49.0 |
| Age Max | 56.0 |
| Age SD | |
| Number of Males | |
| Number of Females | 11 |
| State of Well Being |
Non-healthy (excl pregnant)
|
| Diseases | |
| Study Duration Length | 24 |
| Study Duration Units | Week |
| Sampling Intervals, e.g. X sample(s) per Interval Unit | 1 |
| Interval Units | Week |
| Sampling Times | Start Time:
9:00
End Time: 10:00 |
| Number of Samples | 24 |
| Average Number of Samples Used for BV Estimation | 24.0 |
| Average Number of Replicates | 1.0 |
| Estimates of CVi | 9.0 |
| Calculated Confidence Intervals of CVi | Lower: 8.03, Upper: 9.99 |
| Estimates of CVg | |
| Calculated Confidence Intervals of CVg | Lower: 0.00, Upper: |
| Analytical CV | 3.4 |
| Calculated Confidence Intervals of Analytical CV | Lower: 2.68, Upper: 4.66 |
| Measurand Mean | 14.3 |
| Measurand Min | 10.3 |
| Measurand Max | 21.0 |
| Measurand SD |